India's Twin Epidemic: Diabetes Fuels TB Crisis

India is grappling with a dual epidemic, as rising diabetes rates exacerbate tuberculosis (TB) vulnerabilities. National Family Health Survey-6 data reveals a sharp increase in high blood sugar among Indian adults, now affecting over 19% and making them significantly more prone to TB. This co-morbidity complicates TB treatment, heightens risks, and can lead to drug resistance.

Recognizing this critical link, India's National Programme mandated diabetes screening for all TB patients in 2017. By 2023, 92% of notified TB patients were screened, identifying nearly 180,000 individuals with both conditions. The 'TB-Mukt Bharat Abhiyaan' in December 2024 further expanded screening to include people with diabetes for TB, irrespective of symptoms.

Initiatives like 'Differentiated TB Care' tailor treatment, acknowledging diabetes as a major risk factor. The government also promotes nutrition and healthy lifestyles to prevent both diseases. A crucial proposed step is mandating TB screening, via chest X-ray, for all diabetes patients, with immediate referral for confirmatory tests if lung lesions are detected.

To combat these intertwined epidemics effectively, integrated screening and care must become standard practice. Digital health tools and mobile health units can enhance patient follow-up and extend services to vulnerable populations, accelerating progress towards a TB-free India and addressing the pervasive diabetes challenge.